Summary
Background Little is known about the association between household solid fuel use and sarcopenia risk. Using a nationally representative survey, we investigated the association between solid fuel used for heating and cooking and sarcopenia risk among middle-aged and older Chinese adults.
Methods We leveraged two waves of data from the China Health and Retirement Longitudinal Study (CHARLS); 12,723 participants aged ≥ 45 years from 28 provinces across China were enrolled in 2011. Sarcopenia status was classified according to the Asian Working Group for Sarcopenia 2019 criteria. A total of 3,110 participants without sarcopenia were recruited at baseline and were followed up until 2013. Primary fuel types and durations used for heating and cooking were assessed using a validated questionnaire. Multinomial logistic regression explored the cross-sectional and longitudinal associations between solid fuel use and different stages of sarcopenia.
Findings The prevalence of possible sarcopenia and sarcopenia were 34·8% and 5·7%, respectively. Compared with clean fuel users, those using solid fuel for both heating and cooking had significantly higher risks of possible sarcopenia (odds ratio, [OR] 1·72, 95%CI: 1·54-1·91) and sarcopenia (OR 1·74, 1·31-2·31). During the two-year follow-up, 569 participants (18·3%) developed with possible sarcopenia and 86 (2·8%) had sarcopenia. In the longitudinal analyses, solid fuel use was positively associated with the risk of possible sarcopenia (OR 1·75, 1·32-2·31), and the association was higher in individuals with a longer duration of solid fuel use. However, no significant association was observed with the incidence of sarcopenia. Older adults, with less physical activity might have a higher risk of sarcopenia when exposed to solid fuel.
Interpretation Household solid fuel is associated with a higher risk of sarcopenia among middle-aged and older Chinese adults. These findings provide novel evidence for prioritizing public health policies to promote healthy aging by reducing solid fuel use.
Funding National Natural Science Foundation of China
Evidence before this study We searched PubMed, Google Scholar, and the China National Knowledge Infrastructure for studies published in English and Chinese up to February 1, 2023. We used the search terms (“sarcopenia”) AND (“solid fuel” OR “biomass fuel” OR “coal” OR “air pollution”) and found a recent study that explored the cross-sectional relationship between ambient air pollution and sarcopenia risk in the UK. However, no large population-based study has investigated the effects of household solid fuel use on sarcopenia.
Added value of this study Our study showed for the first time that household solid fuel use is associated with a higher risk of sarcopenia among middle-aged and older Chinese adults. Our findings provide important prospective evidence linking solid fuels to an increased risk of sarcopenia. Reducing solid fuel use can be beneficial in preventing sarcopenia and promoting healthy aging in older adults. To our knowledge, this study is the largest nationwide cross-sectional and longitudinal study to date investigating the association between household fuel types and duration of solid fuel use with different stages of sarcopenia.
Implications of all the available evidence Our findings underscore the importance of improving access to clean fuels to reduce the risk of sarcopenia associated with cooking and heating fuel use. This study extends the knowledge that prioritizes public health policies to mitigate the adverse effects of solid fuel use on sarcopenia and provides implications for further mechanistic research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Natural Science Foundation of China (72204048).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical Review Committee of Peking University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflicts of Interests: None declared
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.